Standout Papers
- Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial (2022)
- Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion (2019)
Citation Impact
74 standout
Citing Papers
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
2024 Standout
Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
2024 Standout
Works of MinShan Chen being referenced
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
2019 Standout
Author Peers
| Author | Hepatology | PFM | Epidemiology | Surgery | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| MinShan Chen | 418 | 225 | 127 | 164 | 9 | 549 | |
| Timothy Fu | 6 | 24 | 24 | 7 | 7 | 274 | |
| Maria Cristina Pedicchio | 31 | 487 | |||||
| Gangadhar S. Mulgund | 4 | 11 | 242 | ||||
| Robert H. Lind | 3 | 13 | 18 | 9 | 454 | ||
| Konstantin Gribanov | 38 | 275 |
All Works
Login with ORCID to disown or claim papers
Loading papers...